B Christopher Ehrlich

Affiliations

  • Chairman And Ceo at Cero Therapeutics Holdings Inc. (CERO), 2025-06-02
  • Chief Executive Officer at Launch One Acquisition Corp. (LPAA), 2024-07-11
  • at Effector Therapeutics Inc. (EFTR), 2024-06-13
  • Director at Transcept Pharmaceuticals Inc (TSPT), 2013-04-11
  • Director at Biomimetic Therapeutics Inc. (BMTI), 2013-03-05
  • Large Shareholder at Tesaro Inc. (TSRO), 2012-07-06
  • Other at Trius Therapeutics Inc (TSRX), 2010-08-10
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
EFTR $0.57 346 $197.22 35,213 2022-10-04 Filing
EFTR $0.55 18,867 $10,376.85 34,867 2022-09-26 Filing
EFTR $4.30 1,000 $4,300.00 16,000 2022-02-18 Filing
EFTR $4.45 2,000 $8,900.00 15,000 2022-02-14 Filing
EFTR $4.75 1,000 $4,750.00 13,000 2022-02-09 Filing